Under construction – not a live service
Sign in
Taking people in SwitzerlandNo phase

Bicycle exercise and lifestyle program for recently diagnosed type 2 diabetes

Tests bicycle exercise plus lifestyle changes in adults with newly found type 2 diabetes.

Plain-language title generated from the registry record
Registry title: Bicycle Exercise and Lifestyle Intervention in Newly Diagnosed Diabetes

Key facts

Where
Basel, Delémont, and Olten, SwitzerlandSee the 3 sites

Where in Switzerland

  • University of BaselBasel, SwitzerlandTaking people
  • Hopital du JuraDelémont, SwitzerlandTaking people
  • Cantonal Hospital OltenOlten, SwitzerlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital, Basel, Switzerland
Trial code
NCT03827382
Record updated
14 February 2025
Original description
The aim of the study is to test the efficacy, feasibility, and safety of a bicycle exercise followed by an intensive lifestyle intervention for 3 months in patients with recent onset and medically untreated type 2 diabetes.Read full original descriptionShow less

Bicycle Exercise and Lifestyle Intervention in Newly Diagnosed Diabetes

The aim of the study is to test the efficacy, feasibility, and safety of a bicycle exercise followed by an intensive lifestyle intervention for 3 months in patients with recent onset and medically untreated type 2 diabetes.

Inclusion: Informed consent as documented by signature; Type 2 diabetes diagnosed within the last two years according to the American Diabetes Association (ADA) criteria; Age ≥ 18 years; HbA1c ≥ 7.5 %.

Exclusion: Anti-diabetic medication for ≥ 24 hours; Previous lifestyle-intervention by an endocrinologist; Clinically instable patient as defined by the physicians on duty including signs of new cardiac ischemia in the ECG, systolic blood pressure ≥ 200 mmHg, fever ≥ 38.5 °C, symptoms of SIRS or reduced vigilance; Inability to perform a bicycle exercise during 30 minutes; Engagement in physical activity more than five times per week; Enrollment in other interventional study.

ClinicalTrials.gov NCT03827382